Olema Pharmaceuticals, Inc. (OLMA)
15.17
+0.11
(+0.73%)
USD |
NASDAQ |
Apr 06, 16:00
15.08
-0.09
(-0.59%)
After-Hours: 20:00
Olema Pharmaceuticals SG&A Expense (TTM) : 21.00M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| EyePoint Plc | 51.70M |
| CytomX Therapeutics, Inc. | 29.84M |
| Corvus Pharmaceuticals, Inc. | 9.252M |
| Protagonist Therapeutics, Inc. | 44.85M |
| Oric Pharmaceuticals, Inc. | 33.19M |